Arylsulfonylaminobenzene derivatives and the use thereof as fact

Details Arylsulfonylaminobenzene derivatives and the use thereof as fact Arylsulfonylaminobenzene derivatives and the use thereof as fact

1995-06-07

1998-04-21

Owens, Amelia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514305, 514357, 514535, 514603, 514604, 564 84, 564 86, 564 90, 564 91, 560 10, 560 13, 562429, 562430, 546133, 546334, A61K 3118, A61K 3124, A61K 3144

Patent

active

057418195

ABSTRACT:
The present invention is directed to non-peptidic factor Xa inhibitors which are useful for the treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases. The factor Xa inhibitors provide compounds of structure: ##STR1## or pharmaceutically acceptable salts thereof; wherein

REFERENCES:
patent: 5385885 (1995-01-01), Gasic et al.
El-Sharief, A.M. et al., "2,5-Dichlorobenzenesulfonamide Derivatives and Their Biological Activities," Indian Journal of Chemistry, 22B: 700-704 (Jul. 1983).
Brana et al., Industrial production of N-(4-pyridylmethyl)benzamide, Chemical Abstracts 96:181160 (1981).
Church and Hoffman, Heparin Cofactor II and Thrombin: Heparin-Binding Proteins Linking Hemostasis and Inflammation, Trends in Cardiovascular Medicine 4(3):140-146 (1993).
Claeson G., Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system, Blood Coagulation and Fibrinolysis 5:411-436 (Jun. 1994).
Coughlin S.R., Molecular Mechanisms of Thrombin Signaling, Seminars in Hematology 31(4):270-277 (Oct. 1994).
Hara et al., DX-9065a, a New Synthetic, Potent Anticoagulant and Selective Inhibitor for Factor Xa, Thrombosis and Hemostasis 71:314-319 (Mar. 1994).
Harker L.A., Strategies for inhibiting the effects of thrombin, Blood Coagulation and Fibrinolysis 5 (Suppl 1):S47-S58 (Jan. 1994).
Hidaka et al., Preparation of sulfonylaminobenzylamine derivatives and heterocycle-containing benzylamine derivatives as ulcer inhibitors, Chemical Abstracts 122:9661 (Mar. 1994).
Lefkovits and Topol, Direct Thrombin Inhibitors in Cardiovascular Medicine, Circulation 90(3):1522-1536 (Sep. 1994).
Markwardt F., Inventory of Coagulation Inhibitors from Animals Feeding on Blood, Thrombosis and Hemostasis 72(3):477-479 (Sep. 1994).
Mellott et al., Acceleration of Recombinant Tissue-Type Plasminogen Activator-Induced Reperfusion and Prevention of Reocclusion by Recombinant Antistasin, a Selective Factor Xa Inhibitor, in a Canine Model of Femoral Arterial Thrombosis, Circulation Research 70:1152-1160 (1992).
Nagahara et al., Dibasic (Amidinoaryl)propanoic Acid Derivatives as Novel Blood Coagulation Factor Xa Inhibitors, Journal of Medicinal Chemistry 37:1200-1207 (Apr. 1994).
Ragosta et al., Specific Factor Xa Inhibition Reduces Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits, Circulation 89:1262-1271 (Mar. 1994).
Raj et al., Long-term Oral Anticoagulant Therapy: Update on Indicators, Therapeutic Ranges, and Monitoring, The American Journal of the Medical Sciences 307(2):128-32 (Feb. 1994).
Seymour et al., Ecotin Is a Potent Anticoagulant and Reversible Tight-Binding Inhibitor of Factor Xa, Biochemistry 33:3949-3959 (Apr. 1994).
Sitko et al., Conjunctive Enhancement of Enzymatic Thrombolysis and Prevention of Thrombotic Reocclusion With the Selective Factor Xa Inhibitor, Tick Anticoagulant Peptide, Circulation 85:805-815 (1992).
Sturzebecher et al., Synthetic Inhibitors of Bovine Factor Xa and Thrombin Comparison of Their Anticoagulant Efficiency, Thrombosis Research 54:245-252 (1989).
Tapparelli et al., Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile, Trends in Pharmacological Sciences 14:366-376 (1993).
Tidwell et al., Strategies for Anticoagulation with Synthetic Protease Inhibitors, Xa Inhibitors versus Thrombin Inhibitors, Thrombosis Research 19:339-349 (1980).
Weitz and Hirsh, New Anticoagulant Strategies, Journal of Laboratory Clinical Medicine 122(4):364-373 (1993).
Yamazaki et al.,Effects of DX-9065a, on Orally Active, Newly Synthesized and Specific Inhibitor of Factor Xa, against Experimental Disseminated Intravascular Coagulation in Rats, Thrombosis and Hemostasis 72(3):393-396 (Sep. 1994).

Affiliated with

Also associated with

Rating

Arylsulfonylaminobenzene derivatives and the use thereof as fact does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylsulfonylaminobenzene derivatives and the use thereof as fact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonylaminobenzene derivatives and the use thereof as fact will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2057889